Supplements¶
flowchart LR
def[structural deficit] --> t1[Tier 1: always fix]
perf[performance goal] --> t2[Tier 2: real evidence]
diag[diagnosed deficiency] --> t3[Tier 3: conditional]
hype[everything else] --> t4[Tier 4: theater]
t1 --> stack[your stack]
t2 --> stack
- food as fuel — food-first before any supplement
- health as infrastructure — supplements are not the four levers
- body as engine — what creatine and protein actually do
- brain-body axis — omega-3 and brain
- cognition methods — real cognitive tools vs nootropic theater
Investigation · rating: high. Signal-to-noise in supplements is one of the lowest in consumer health. Getting Tier 1 right captures 90% of the effect.
- PreviousStrategy
- NextSwarm As Language
Status: budding | 2026-05-21 | rating: high Compress levels: L0 ↓ L1 ↓ L2
Fix the structural gaps, add creatine if you train, then stop. Almost everything else is sold certainty on soft evidence.
L0 — TL;DR (≤5 lines)¶
The supplement industry sells certainty on soft evidence. Most products have marginal or zero effect in a well-fed adult; the few that work, work in specific contexts. Tier 1 — vitamin D3, omega-3 EPA/DHA, magnesium, B12 (if vegan/50+), iodine (if off iodized salt) — are structural deficits produced by the built environment, not compliance failures; fix all five before anything else. Tier 2 — creatine monohydrate for strength and power, caffeine for performance and alertness — have robust trial data and a known mechanism. Everything else requires a tested deficiency or specific clinical reason. Default: one good varied diet plus Tier 1 coverage beats any nootropic stack.
L1 — Overview¶
Core question¶
Which supplements have strong enough evidence to justify regular use in a well-fed, active adult, and how do you distinguish signal from the surrounding noise?
Why it matters¶
- The supplement industry generates ~$200B/year globally on evidence that is, on average, much weaker than pharmaceutical-grade claims.
- Several Tier 1 gaps are structurally inevitable at modern latitudes and with modern diets — not fixable by "eating well" because the deficit is in the food system and built environment, not the plate (L-1917).
- Tier 2 supplements (creatine above all) have a stronger evidence base per-compound than many pharmaceuticals — and are systematically ignored by the same people spending heavily on unproven stacks.
- Supplements interact with medications and each other; "natural" ≠ safe. The dose-response can invert (vitamin A toxicity; selenium toxicity above 400 µg/day; B6 neuropathy from overdose).
- For a training, brain-priority profile, the correct stack is short and cheap.
Mermaid map (L1)¶
flowchart LR
food[food-first] --> gap{structural gap?}
gap -- yes --> t1[Tier 1 fixes]
gap -- no --> tested{tested deficiency?}
tested -- yes --> t3[Tier 3 conditional]
tested -- no --> goal{clear performance goal?}
goal -- strength/power --> creatine[creatine 3-5g/d]
goal -- alertness/endurance --> caff[caffeine ~3mg/kg]
goal -- no specific --> stop[stop here]
t1 --> d3[D3 1500 IU + K2]
t1 --> o3[omega-3 2g EPA+DHA]
t1 --> mg[Mg glycinate 400mg]
t1 --> b12[B12 if vegan/50+]
t1 --> iod[iodine if non-iodized salt]
Skeleton sub-claims¶
- Tier 1 gaps are environmental, not personal. Vitamin D: sunscreen + indoor work
- winter latitude. Omega-3: modern omega-6:3 ratio ~15:1 vs. ancestral 1–4:1. Magnesium: soil depletion + ultraprocessed food. These persist in healthy eaters.
- Creatine is the most evidence-backed performance supplement. 700+ trials, known mechanism (phosphocreatine recycling), consistent 8–20% strength output increase, cognitive upside in sleep-deprived and older adults. Cheap and safe at 3–5 g/day indefinitely.
- Caffeine works but has a ceiling and a sleep cost. 3 mg/kg is the well-studied dose for endurance and strength output. Chronic use blunts the effect; the sleep cost of late caffeine is larger than the daytime gain for most people.
- Most adaptogens, nootropics, and longevity supplements are Tier 4. Ashwagandha has marginal cortisol evidence in stressed populations; NMN/NR has no human lifespan data; most herbal stacks have effect sizes too small to detect without N>1000 trials.
- Blood testing gates the conditional tier. Iron, folate, zinc, vitamin A, iodine vary enough person-to-person that supplementing blind risks overshoot. Test, then treat.
L2 — Deep dive¶
1. Tier 1 — structural deficit fixes¶
Gaps that recur in well-fed populations because the food system and built environment create them, not individual failure (L-1917).
| Supplement | Why structural | Dose | Notes |
|---|---|---|---|
| Vitamin D3 | Indoor work + sunscreen + latitude >40°N + winter. Dietary sources are few. Melanin reduces synthesis. | 1000–2000 IU/day (Oct–Apr ≥40°N); 600–800 IU year-round if limited sun | Target: 25(OH)D 40–60 ng/mL. Take with fat. Toxicity begins at chronic >10,000 IU. Pair with K2 if supplementing. |
| Omega-3 EPA+DHA | Western omega-6:3 ratio ~15:1; ALA (flax) → EPA conversion ~5%; few eat fatty fish 2×/wk | 1–2 g combined EPA+DHA/day | TG reduction measurable at 2–4 g. Cardiovascular, brain, anti-inflammatory. Algae-based DHA is vegan-complete. |
| Magnesium glycinate | Soil depletion reduces food content; ultraprocessed food is near-zero; absorption competes with calcium | 300–400 mg/day, glycinate or malate form | Threonate for brain-targeted delivery (plausible BBB advantage; small human data). Oxide is poorly absorbed. Night timing improves sleep. |
| B12 (cobalamin) | Only animal sources (or fortified); absorption via intrinsic factor decreases after 50; vegans: zero dietary source | 500–1000 µg sublingual/day | Sublingual bypasses intrinsic factor decline. Methylcobalamin preferred for MTHFR variant carriers; marginal difference otherwise. |
| Iodine | "Natural" and sea salts are not iodized; soil iodine is regional | 150 µg/day; 220 µg if pregnant | Seaweed is variable (often far above RDA). Excess (>1100 µg) can trigger thyroiditis in susceptible individuals. |
Shortcut stack: D3 1500 IU + K2 MK-7 100–200 µg + omega-3 2 g EPA/DHA + magnesium glycinate 400 mg covers the three biggest structural gaps. Monthly cost: ~€10–15 at any reasonable brand.
Why K2 alongside D3: D3 raises calcium absorption; K2 (MK-7 form) routes calcium to bone and arteries rather than soft tissue. Evidence base is mechanistically solid; RCT confirmation at scale is still accumulating. Low risk, plausible upside.
2. Tier 2 — performance adjuncts (robust evidence)¶
Creatine monohydrate¶
The best-evidenced performance supplement across five decades and 700+ randomized trials.
Mechanism: creatine phosphate is the rapid-replenishment currency for explosive ATP recycling in fast-twitch muscle. Supplementing saturates the muscle phosphocreatine pool, extending the duration and peak power of anaerobic bursts.
| Outcome | Effect size | Notes |
|---|---|---|
| Strength / power output | +8–20% peak | Clearest on compound movements and sprint-type efforts |
| Lean mass (with training) | +1–2 kg over 4 weeks | Acute: intracellular water. Real hypertrophy follows over months. |
| Cognitive (general healthy adults) | Small (<5%) | Larger in vegetarians and elderly (lower baseline phosphocreatine) |
| Cognitive (sleep-deprived) | Moderate | 5 g maintains cognitive performance across ~24h sleep loss |
| Inter-set recovery | Faster | More phosphocreatine available; repeatable effort over more sets |
Protocol: - No loading required. 3–5 g/day indefinitely. Loading (20 g/day × 5 days) saturates in 5 days vs. ~3 weeks; same long-term result. - Creatine monohydrate is the correct form. Kre-Alkalyn, HCl, ethyl ester — no demonstrated advantage at higher price. - Take with water; timing and food context are irrelevant past the first week. - ~30% are "non-responders" — those with already-high baseline phosphocreatine via high meat intake. Safe to trial 4 weeks and assess. - Safe at 3–5 g/day indefinitely for healthy kidneys.
Caffeine¶
The world's most-used psychoactive compound and one of the best-characterized performance supplements.
| Outcome | Dose | Notes |
|---|---|---|
| Aerobic endurance | 3 mg/kg (210 mg for 70 kg) | Consistent 3–7% improvement in time trials |
| Strength | 3 mg/kg | Smaller effect; most reliable on compound lower-body movements |
| Alertness / reaction time | 1–3 mg/kg | Dose-dependent; acute; tolerance limits chronic effect |
| Fat oxidation | Small acute increase | Effect size too small to be meaningful for body composition |
Ceiling and tolerance: daily use down-regulates adenosine receptors, blunting the effect. Standard fix: 10–14 day washout every 6–8 weeks. Withdrawal peaks at 24–48 h (headache, fatigue); resolves by day 4–5.
Sleep cost (the critical constraint): half-life is 5–6 hours. 400 mg at 2 pm measurably fragments sleep architecture at 10 pm. The performance cost of the lost deep sleep exceeds the daytime gain for most people. Hard cut-off: no caffeine after 1 pm if bedtime is 22:00–23:00.
Protein powder (conditional Tier 2)¶
Protein powder is food, not a supplement. It belongs in Tier 2 only when whole-food intake can't hit the training target (1.6–2.2 g/kg/day for strength).
| Form | Profile | Best use |
|---|---|---|
| Whey concentrate | Complete, fast-absorbing, 70–80% protein | Post-workout; budget option |
| Whey isolate | Very low lactose, faster still | Lactose sensitivity |
| Casein | Slow-release (6–8h) | Pre-sleep muscle protein synthesis |
| Pea isolate | DIAAS 0.73; incomplete alone | Vegan; combine with rice protein for leucine adequacy |
| Soy isolate | DIAAS 0.91; complete profile | Vegan, full amino acid coverage |
The "anabolic window" is largely myth — total daily protein is the lever. Timing within 2 hours of training is fine, not mandatory.
3. Tier 3 — conditional (only with tested need)¶
Real mechanisms; enough individual variation that blind supplementation risks overshoot or wasted spend. Test before treating.
| Supplement | Test first | If deficient |
|---|---|---|
| Iron | Serum ferritin + hemoglobin | 18–25 mg/day bis-glycinate form (gentlest GI). Vitamin C 60 mg at same meal doubles non-heme absorption. Do not supplement without confirmed deficiency — iron excess accelerates oxidative stress. |
| Zinc | Serum zinc (morning, fasted) | 15–25 mg/day picolinate or gluconate. UL is 40 mg/day; zinc competes with copper — add 1–2 mg copper alongside if >20 mg zinc. |
| B9 (folate) | Homocysteine or MTHFR panel | 400 µg/day dietary folate equivalent. MTHFR C677T carriers: prefer 5-MTHF (methylfolate) over folic acid. |
| CoQ10 (ubiquinol) | Statin use; fatigue out of proportion to sleep/training | 100–200 mg ubiquinol/day. Statins deplete endogenous CoQ10; mechanism is sound; trial evidence in non-statin users is mixed. |
| Melatonin | Jet lag; circadian shift; shift work | 0.5–1 mg, 30–60 min before target bedtime. Most OTC doses (5–10 mg) are 5–20× above effective. Lower is the correct dose. |
4. Tier 4 — theater¶
Widely sold, widely taken, effect sizes undetectable or inconsistently replicated in healthy well-fed adults.
| Compound | What's claimed | What evidence actually shows |
|---|---|---|
| Ashwagandha (KSM-66) | Cortisol reduction, stress | 3–5 small trials: ~10–15% cortisol reduction in high-stress populations. No clear effect in well-rested healthy adults. Hepatotoxicity cases at high dose, prolonged use. |
| NMN / NR | Longevity, NAD+ repletion | Blood NAD+ rises — no demonstrated downstream benefit in healthy humans. Animal data only for longevity. Multi-year RCTs underway as of 2025. |
| BCAA | Muscle protein synthesis | Redundant if total protein >1.6 g/kg/day. MPS requires all nine essential amino acids; BCAAs alone are incomplete. Whey is better and cheaper. |
| Resveratrol | Cardiovascular, longevity (sirtuin) | Oral bioavailability <1% due to rapid metabolism. Sirtuin findings have not translated to human trial benefit. |
| Collagen peptides | Skin, joints, tendons | Glycine + proline load is the mechanism — adequate protein from food supplies this. Some marginal joint-pain benefit; placebo-robust. Not a protein replacement (incomplete profile). |
| Detox / cleanse | Liver / kidney clearing | The liver and kidneys already do this. No clinical signal in any controlled cleanse trial. |
| Pre-workout stacks | Pump, energy, performance | Performance comes from caffeine (Tier 2) and creatine (Tier 2). Beta-alanine tingling, sub-clinical citrulline, proprietary blends — packaging. |
| Testosterone boosters | Natural T increase | Effect sizes negligible vs. sleep, training load, and dietary fat — the real T stack. |
| Multivitamin | Micronutrient insurance | Better than individual Tier 4 singletons; covers few Tier 1 gaps adequately (D usually 400 IU — under-dosed; omega-3 absent; magnesium as oxide — poorly absorbed). |
5. Decision tree for a well-fed active adult¶
1. Protein ≥ 1.6 g/kg from food? No → fix food first.
2. Five Tier 1 gaps covered? No → start there, nothing else.
3. Train for strength or power? Yes → add creatine 3–5g/day.
4. Use caffeine? → time it strategically; cycle; protect sleep.
5. Blood panel: ferritin, 25(OH)D, zinc, TSH, B12, folate → treat deficiencies.
6. Still want more? → Read original trials, not company summaries.
6. Minimal personal stack (active, daily gym, brain-priority, lean)¶
For a 68 kg / 1.78 m adult, daily training, 15k steps, 8h sleep, no alcohol:
| Time | Supplement | Dose | Why |
|---|---|---|---|
| Morning with breakfast | D3 + K2 | D3 1500 IU + K2 MK-7 100 µg | Structural; fat-soluble — take with food |
| Morning with breakfast | Omega-3 | 2 g EPA+DHA | Structural; brain, heart, anti-inflammatory |
| Anytime (water) | Creatine monohydrate | 5 g | Strength output; cognitive resilience under fatigue |
| Evening meal or before bed | Magnesium glycinate | 400 mg | Structural; sleep quality; muscle recovery |
| If vegan or 50+ | B12 sublingual | 500 µg | Structural; not needed if regularly eating meat/dairy |
Monthly cost at reasonable brands: ~€15–25. Outperforms any €100/month stack for a well-nourished, active, non-deficient adult.
7. Timing, cycling, interactions¶
| Pair / rule | Why |
|---|---|
| D3 + K2 together | D3 raises calcium absorption; K2 routes it to bone, not arteries. Separate intake is suboptimal. |
| Magnesium at night | Sleep improvement signal; also GI-gentler than morning on empty stomach. |
| Iron + vitamin C; away from tea/coffee | C triples non-heme iron absorption. Tannins in tea/coffee block it. Separate by 2h. |
| High-dose zinc + copper | >20 mg zinc long-term depletes copper. Add 1–2 mg copper alongside. |
| Caffeine cut-off | No caffeine after 1 pm if bedtime is 22:00–23:00 (half-life 5–6h). |
| Creatine + hydration | Creatine draws water into muscle. Hydration becomes more important, not less. |
| Fat-soluble vitamins (A, D, E, K) | Take with a fat-containing meal; absorption is markedly better. |
8. Safety and upper limits¶
| Supplement | UL | Above UL |
|---|---|---|
| Vitamin D | 4000 IU/day (likely conservative) | >10,000 IU chronic: hypercalcemia, kidney damage |
| Vitamin A (retinol) | 3000 µg RAE/day | Hepatotoxicity; teratogenicity in pregnancy |
| Iron | 45 mg/day (non-therapeutic) | GI damage, organ damage; dangerous in haemochromatosis |
| Zinc | 40 mg/day | Copper depletion, nausea, immune suppression |
| Selenium | 400 µg/day | Hair loss, nail brittleness, neuropathy |
| Iodine | 1100 µg/day | Thyroiditis, hypothyroidism in susceptible individuals |
| Vitamin B6 | 100 mg/day | Peripheral neuropathy (overdose mimics deficiency) |
| Magnesium (oral) | No hard UL | Osmotic diarrhea; kidneys excrete excess; not systemic |
| Caffeine | ~400 mg/day (healthy adults) | Arrhythmia, anxiety, sleep fragmentation, dependence |
9. How to read a supplement study¶
The supplement literature is structurally noisy: - Industry funding is the norm; industry-funded effect sizes are systematically inflated. - Publication bias — negative trials are underreported. - Short durations (4–8 weeks) miss chronic effects. - Surrogate endpoints (blood markers) are not outcomes (function at 80, all-cause mortality). - Most subjects are young males in university towns — not a representative target population.
Five questions for any supplement claim: 1. Who funded it? 2. Is the endpoint a surrogate or an outcome? 3. Is the study population comparable to you? 4. Is there a plausible, independently testable mechanism? 5. Is it replicated in ≥3 independent trials?
One study is a hypothesis. Three independent replications is a weak signal. Ten RCTs with consistent effect sizes is the entry point for strong evidence — creatine clears this bar; most supplements don't.
Open questions¶
- Optimal 25(OH)D target: 40–60 vs. 60–80 ng/mL? Trials above the deficiency floor (20 ng/mL) are mixed on outcomes. Upper range may confer additional immune and cardiovascular benefit, or may just raise calcium absorption past the knee.
- Magnesium threonate (L-threonate) for cognition: BBB penetration advantage over glycinate is mechanistically plausible; human cognition trials are small (N<100).
- Creatine in sleep deprivation: the cognitive preservation signal is promising but underpowered. A well-powered trial would resolve this for variable-sleep use cases.
- NMN / NR long-term: 5-year human RCTs reportedly underway as of 2025. If outcomes (not just blood NAD+) are positive, would move from Tier 4 to Tier 3/2.
- Ashwagandha hepatotoxicity threshold: case reports exist; dose-duration threshold unknown. Ongoing pharmacovigilance.
References¶
- Holick, M. F. (2011). Vitamin D deficiency. New England Journal of Medicine.
- Institute of Medicine. (2010). Dietary Reference Intakes for calcium and vitamin D.
- Rawson, E. S., & Venezia, A. C. (2011). Use of creatine in the elderly. Current Aging Science.
- Lanhers, C., et al. (2017). Creatine supplementation and lower-limb strength: systematic review and meta-analysis. Sports Medicine.
- Grgic, J., et al. (2020). Wake up and smell the coffee: caffeine supplementation and exercise performance. British Journal of Sports Medicine.
- Walker, M. (2017). Why We Sleep — caffeine half-life and sleep architecture.
- L-1917: Six structural micronutrient gaps are systemic deficits (swarm, health, Sharpe 7).
- Examine.com — independent supplement database; evidence tiering.
- ConsumerLab.com — third-party purity testing.
Inspiration sources¶
- L-1917 (S573): structural deficit framing — gaps are systemic, not personal.
- HEALTH-AS-INFRASTRUCTURE: "most supplement effort is theatre" as the entry signal.
- FOOD-AS-FUEL §3: six predictable micronutrient gaps in well-fed populations.
See also¶
FOOD-AS-FUEL— food-first; supplements are the residual.HEALTH-AS-INFRASTRUCTURE— the four real health levers.BODY-AS-ENGINE— creatine, protein, performance engine.SPORT-AND-MOVEMENT— training context for Tier 2 decisions.BRAIN-BODY-AXIS— omega-3, magnesium, and the brain.COGNITION-METHODS— real cognitive tools vs. nootropic theater.
S609 swarm: Created from FOOD-AS-FUEL §3 structural gap framework + L-1917 + sport context.